WallStreetZenWallStreetZen

NYSEMKT: PTHS
Pelthos Therapeutics Inc Stock Ownership - Who owns Pelthos Therapeutics?

OverviewEarningsRevenueDividendOwnership

Insider buying vs selling

Have Pelthos Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Todd C. DavisDirector2025-07-011,500,000$10.00
$15.00MBuy
Knuettel Francis IiChief Financial Officer2025-07-0110,000$10.00
$100.00kBuy
Ezra M. FriedbergDirector2025-07-0140,000$10.00
$400.00kBuy
Ezra M. FriedbergDirector2025-07-0140,000$10.00
$400.00kBuy
Ligand Pharmaceuticals Inc10% Owner2025-07-011,500,000$10.00
$15.00MBuy
Knuettel Francis IiCEO Pres. CFO Treas Secty2024-09-133,500$0.97
$3.40kBuy
Richard MalamutDirector2024-09-1210,400$0.95
$9.83kBuy
Knuettel Francis IiCEO Pres. CFO Treas Secty2024-09-121,700$0.97
$1.65kBuy
Knuettel Francis IiCEO Pres. CFO Treas Secty2024-09-115,500$0.94
$5.17kBuy
Knuettel Francis IiCEO Pres. CFO Treas Secty2024-09-106,500$0.89
$5.79kBuy

1 of 1

PTHS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PTHS insiders and whales buy or sell their stock.

PTHS Shareholders

What type of owners hold Pelthos Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Todd C. Davis49.40%1,502,917$31.50MInsider
Ligand Pharmaceuticals Inc49.31%1,500,000$31.44MInsider
Ezra M. Friedberg21.54%655,292$13.73MInsider
Motif Pharmaceuticals Ltd15.47%470,674$9.87MInsider
Boswell Prayer Ltd15.12%459,895$9.64MInsider
Aperture Healthcare Ventures Ltd14.02%426,566$8.94MInsider
Ame Equities LLC11.54%351,163$7.36MInsider
Knuettel Francis Ii5.05%153,769$3.22MInsider
Millennium Management LLC4.49%136,712$2.87MInstitution
Richard Malamut3.01%91,565$1.92MInsider

1 of 2

PTHS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PTHS2.57%97.43%Net BuyingNet Buying
CUE22.58%7.36%Net Buying
GNTA2.94%0.00%
IMMX8.11%31.45%Net BuyingNet Buying
MNOV10.54%89.10%
View Top Biotech Stocks

Pelthos Therapeutics Stock Ownership FAQ

Who owns Pelthos Therapeutics?

Pelthos Therapeutics (NYSEMKT: PTHS) is owned by 4.86% institutional shareholders, 184.47% Pelthos Therapeutics insiders, and 0.00% retail investors. Todd C. Davis is the largest individual Pelthos Therapeutics shareholder, owning 1.50M shares representing 49.40% of the company. Todd C. Davis's Pelthos Therapeutics shares are currently valued at $31.50M.

If you're new to stock investing, here's how to buy Pelthos Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.